Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Vericel Corp
VCEL
$2.31B
| $888K | ﹤0.01% |
46,964
+1,281
| +3% | +$21.8K |
|
3752
PUT
Molina Healthcare
MOH
$10.3B
| $887K | ﹤0.01% |
6,200
-14,200
| -70% | -$1.95M |
|
3753
PUT
Marriott Vacations Worldwide
VAC
$4.25B
| $887K | ﹤0.01% |
9,200
+3,700
| +67% | +$365K |
|
3754
PUT
Archer Daniels Midland
ADM
$36.9B
| $885K | ﹤0.01% |
21,700
+10,500
| +94% | +$435K |
|
|
VAR
3755
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
| $885K | ﹤0.01% |
6,500
+3,400
| +110% | +$454K |
|
|
MODV
3756
DELISTED
ModivCare
MODV
| $883K | ﹤0.01% |
15,399
-7,646
| -33% | -$495K |
|
|
TRST
3757
Trustco Bank Corp NY
TRST
$938M
| $883K | ﹤0.01% |
22,287
+9,184
| +70% | +$356K |
|
|
CHCT
3758
Community Healthcare Trust
CHCT
$454M
| $882K | ﹤0.01% |
22,381
-24,224
| -52% | -$902K |
|
3759
Coherus Oncology
CHRS
$196M
| $882K | ﹤0.01% |
39,905
+19,622
| +97% | +$341K |
|
3760
Acushnet Holdings
GOLF
$5.45B
| $881K | ﹤0.01% |
33,561
+16,232
| +94% | +$403K |
|
3761
PUT
Expeditors International
EXPD
$23.2B
| $880K | ﹤0.01% |
11,600
+11,400
| +5,700% | +$860K |
|
3762
CALL
Reliance Steel & Aluminium
RS
$21.6B
| $880K | ﹤0.01% |
9,300
+7,800
| +520% | +$698K |
|
3763
CALL
Sempra
SRE
$54.8B
| $880K | ﹤0.01% |
12,800
+10,600
| +482% | +$695K |
|
3764
Fossil Group
FOSL
$318M
| $879K | ﹤0.01% |
76,544
+22,343
| +41% | +$274K |
|
3765
Barclays
BCS
$94.1B
| $878K | ﹤0.01% |
117,786
| – | – |
|
3766
Helios Technologies
HLIO
$2.76B
| $877K | ﹤0.01% |
18,890
-12,363
| -40% | -$577K |
|
|
KSU
3767
CALL
DELISTED
Kansas City Southern
KSU
| $877K | ﹤0.01% |
7,200
-433,700
| -98% | -$51.9M |
|
|
BHVN
3768
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $876K | ﹤0.01% |
+20,000
| New | +$1.13M |
|
|
HTZ
3769
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $875K | ﹤0.01% |
54,800
+588
| +1% | +$8.85K |
|
3770
Vicor
VICR
$10.2B
| $874K | ﹤0.01% |
28,173
+4,733
| +20% | +$152K |
|
3771
Amphastar Pharmaceuticals
AMPH
$916M
| $873K | ﹤0.01% |
41,401
+10,352
| +33% | +$216K |
|
3772
Sonic Automotive
SAH
$2.61B
| $872K | ﹤0.01% |
37,320
+14,144
| +61% | +$272K |
|
3773
PUT
TE Connectivity
TEL
$62.6B
| $872K | ﹤0.01% |
9,100
+100
| +1% | +$9.02K |
|
3774
PUT
Sanofi
SNY
$104B
| $870K | ﹤0.01% |
20,100
-81,100
| -80% | -$3.45M |
|
|
ZYNE
3775
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $870K | ﹤0.01% |
64,200
+58,502
| +1,027% | +$675K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.